Study of Shatavari Root Extract to Improve Womens Sexual Wellness and Reduce Stress Randomized, Double-Blind, Placebo-Controlled Trial for Women Ages 20 to 50

What this Trial Is About

This trial investigates the effects of a standardized Shatavari Asparagus racemosus root extract on womens sexual wellness, focusing on sexual function, distress, satisfaction, stress, quality of life, and physiological stress markers. The study is a randomized, double-blind, placebo-controlled clinical trial involving women aged 20 to 50 years with reduced sexual function and elevated stress. It aims to evaluate the efficacy and safety of Shatavari root extract in improving these aspects of sexual wellness. Participants will be randomly assigned to one of two groups one receiving a daily 300 mg capsule of Shatavari root extract and the other receiving a matching placebo capsule containing starch. Both treatments are taken orally once daily after breakfast for 12 weeks. The study is conducted in multiple countries and follows a parallel-group design with quadruple blinding to ensure unbiased results. Throughout the 12-week trial, participants will undergo assessments at baseline and at weeks 4, 8, and 12, including questionnaires measuring sexual function, distress, satisfaction, perceived stress, and quality of life. Salivary cortisol tests and laboratory evaluations of thyroid, liver, and kidney functions will also be performed. Safety is monitored by recording adverse events from baseline to week 12. Participants are expected to comply with study procedures and attend scheduled visits for thorough monitoring and evaluation.

Efficacy and Safety of Shatavari Root Extract in Women's Sexual Wellness